Anthony Vecchione
ArteraAI Prostate forecasts potential long-term outcomes of a patient's prostate cancer biopsy slide based on digital pathology images.
The financing comes on top of the company's $900 million annual research and development investment in the U.S.
The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.
The alliance aims to benefit patients with chronic conditions and allow real-time interoperability among healthcare providers, pharmacies and payers.
Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients when action is advised.
Maven Clinic introduces male fertility support tools, Scripta Insights announces a tool to locate cost-effective meds, and XRHealth launches a new platform.
Nyxoah is in the midst of a lawsuit brought on by Inspire Medical Systems alleging infringement of several patents related to its recently-cleared offering, Genio.
The company began trading on Nasdaq under the ticker symbol HTFL, opening at $19.00 per share.
The Conference Board's principal economic policy analyst PJ Tabit says that while the plan is helpful, it is not a comprehensive framework for how to regulate AI.
The acquisition comes amid OpenEvidence's lawsuit alleging that Pathway Medical stole trade secrets, which Pathway has denied.